Scope of the Conference
The Weinstein Cardiovascular Development and Regeneration Meeting is an annual, freestanding meeting that began from a series of annual meetings in which investigators funded by three separate RFAs on Cardiac Development came together in 1986, 1988, and 1990 under the direction of Constance Weinstein and colleagues at the NHLBI. After the final RFA expired in 1993, there was strong motivation to continue these fruitful and informative meetings in a different and extended format. In 1994, Dr. Roger Markwald organized the first independent meeting at MUSC in Charleston, and one year later, when the meeting was held at the University of Rochester, the meeting was formally named the “Weinstein Cardiovascular Development Conference” (or Weinstein Meeting) to honor Dr. Connie Weinstein upon her retirement from the NIH. In 1996, Dr. Clayton Buck and colleagues hosted the meeting at the University of Pennsylvania. During these first independent conferences, the general meeting organization and governance structure was established that continues today. In 2004, the Weinstein meeting outside the US was first held at the Leiden University, the Netherland (2004), followed by the University of Amsterdam (2010), the Netherland and CNIT, in Madrid, Spain (2014).
Since its inception, the Weinstein meeting has been the premier opportunity for researchers in the field of cardiovascular development to meet and share data and ideas. During this 3-day meeting, basic scientists, clinicians and physician-scientists interact and discuss many diverse aspects related to cardiovascular embryology and its impact on congenital heart disease and adult cardiac dysfunction. Our understanding of how the cardiovascular system develops has grown in direct relationship to expansion of the Weinstein Meeting, and thus its key objectives are to continue to promote a collegiate environment for dissemination and discussion of innovative scientific findings, and encourage interactions and collaborations. Additional, innovative scientific objectives for the 2020 meeting include a focus on cardiovascular regeneration and tissue engineering.
Organization of the Conference
In order to provide a corporate memory and to maintain quality the conference, the participants of the 1998 meeting voted to form an organizing committee called the “Weinstein Committee”. The makeup of the committee is comprised of representatives from each of the three previous local organizing committees, representatives from the next two proposed meeting sites, and two “At Large” members voted upon by the conference participants. The “At Large” members will serve a three-year term. The charge to the Committee is to assist the local organizing committee with meeting arrangements and organization and to help secure funding.
In addition, the Committee is charged with soliciting nominations for future meeting sites and hosts. Such nominations will then be brought up for a vote by the attendees during the business meeting. Meeting sites will be selected by vote such that the local organizing committee will have a two-year lead-time. In the event that multi-year funding is sought from the National Institutes of Health or other national sources, the Weinstein Committee will participate in this process.
Obligations of the Participants
One of the most important aspects of the Weinstein Meeting has been the willingness of the participants to share new and unpublished information. This has provided opportunities for the participants to devise new experiments and develop new hypotheses in a collaborative manner. It is expected that all participants will participate in a collegial and ethical manner with respect to information obtained at the Weinstein Meeting. Permission should be obtained before disclosure of another investigator’s unpublished data.
Similarly, investigators pursuing similar experiments should inform a presenter if the divulged information has a bearing on their own work. All participants in the conference should be willing to share their expertise and reagents in the collective advancement of the area of cardiovascular development.
Annual Business Meeting
Each Weinstein Meeting will include time set aside for a business meeting. At this time participants will vote on future host and meeting site selection and may consider changes in the direction of the conference or its organization. At the 1999 meeting in Tucson, Arizona this Charter was distributed to the participants and ratified. Its provisions commenced at the business meeting of the 1999 Tucson, Arizona Conference. The Charter will remain in effect until modified by a vote of participants at an annual business meeting.
1995 University of Rochester, Rochester, NY
1996 University of Pennsylvania, Philadelphia, PA
1997 University of Cincinnati, Cincinnati, OH
1998 Vanderbilt University, Nashville, TN
1999 University of Arizona, Tucson, AZ
2000 University of Washington, St. Louis, MI
2001 University of Texas, South Western Medical School, Dallas, TX
2002 University of Utah, Salt Lake City, UT
2003 Harvard University, Cambridge, MA
2004 Leiden University, Leiden, The Netherland
2005 University of Arizona, Tucson, AZ
2006 University of South Florida, St. Petersburg, FL
2007 Indianapolis University School of Medicine, Indianapolis, IN
2008 Texas A&M University, Houston, TX
2009 University of California San Francisco, San Francisco, CA
2010 University of Amsterdam, Amsterdam, The Netherland
2011 University of Cincinnati, Cincinnati, OH
2012 University of Chicago, Chicago, IL
2013 University of Arizona, Tucson, AZ
2014 Centro Nacional de Investigaciones Cardiovasculares , Madrid, Spain
2015 Boston Children’s Hospital, Boston, MA
2016 Duke University, Durham, NC
2017 Nationwide Children’s Hospital, Columbus, OH